Literature DB >> 11749695

Expression profile of histone deacetylase 1 in gastric cancer tissues.

J H Choi1, H J Kwon, B I Yoon, J H Kim, S U Han, H J Joo, D Y Kim.   

Abstract

Although histone deacetylases (HDACs) appear to play a crucial role in carcinogenesis, the expression status of HDACs in primary human cancer tissues has not yet been reported. In this study, we investigated the expression level of HDAC1 in 25 paired primary human gastric cancer (GC) tissues and corresponding normal tissues through semi-quantitative RT-PCR and immunoblot analysis. The HDAC1 expression pattern was also topologically examined through immunohistochemistry. Overexpression of HDAC1 mRNA was detected in 68% of GC tissues (17 of 25), and the relative density of HDAC1 mRNA in GC tissue was increased 1.8-fold versus the normal counterpart (P < 0.01). Elevated expression of HDAC1 protein was also detected in 61% of GC samples (11 of 18), which also showed an increased mRNA level of HDAC. Immunohistochemically, overexpression of HDAC1 was predominantly localized in the nuclei of most neoplastic cells, including embolic tumor cells, whereas normal glandular epithelial cells revealed only weak HDAC1 expression that was focal in distribution. Thus, the present study clearly demonstrates that HDAC1 is overexpressed in GC and probably plays a significant role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11749695      PMCID: PMC5926683          DOI: 10.1111/j.1349-7006.2001.tb02153.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

Review 1.  The human histone deacetylase family.

Authors:  S G Gray; T J Ekström
Journal:  Exp Cell Res       Date:  2001-01-15       Impact factor: 3.905

2.  Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells.

Authors:  J Y Shin; H S Kim; J Park; J B Park; J Y Lee
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

Review 3.  Roles of histone acetyltransferases and deacetylases in gene regulation.

Authors:  M H Kuo; C D Allis
Journal:  Bioessays       Date:  1998-08       Impact factor: 4.345

Review 4.  Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs.

Authors:  C A Hassig; S L Schreiber
Journal:  Curr Opin Chem Biol       Date:  1997-10       Impact factor: 8.822

Review 5.  Histone acetylation in chromatin structure and transcription.

Authors:  M Grunstein
Journal:  Nature       Date:  1997-09-25       Impact factor: 49.962

6.  Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Authors:  M Yoshida; M Kijima; M Akita; T Beppu
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

7.  Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.

Authors:  M S Kim; H J Kwon; Y M Lee; J H Baek; J E Jang; S W Lee; E J Moon; H S Kim; S K Lee; H Y Chung; C W Kim; K W Kim
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

8.  Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase.

Authors:  M Kijima; M Yoshida; K Sugita; S Horinouchi; T Beppu
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

9.  Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate.

Authors:  F Dangond; S R Gullans
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

Review 10.  Histone acetylation and control of gene expression.

Authors:  B M Turner
Journal:  J Cell Sci       Date:  1991-05       Impact factor: 5.285

View more
  103 in total

Review 1.  Macrocyclic histone deacetylase inhibitors.

Authors:  Sandra C Mwakwari; Vishal Patil; William Guerrant; Adegboyega K Oyelere
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 2.  Multiple roles of class I HDACs in proliferation, differentiation, and development.

Authors:  Nina Reichert; Mohamed-Amin Choukrallah; Patrick Matthias
Journal:  Cell Mol Life Sci       Date:  2012-07       Impact factor: 9.261

3.  Distribution of histone deacetylases 1-11 in the rat brain.

Authors:  Ron S Broide; Jeff M Redwine; Najla Aftahi; Warren Young; Floyd E Bloom; Christopher J Winrow
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

4.  HDAC1 inhibition by maspin abrogates epigenetic silencing of glutathione S-transferase pi in prostate carcinoma cells.

Authors:  Xiaohua Li; Alexander Kaplun; Fulvio Lonardo; Elisabeth Heath; Fazlul H Sarkar; Jonathan Irish; Wael Sakr; Shijie Sheng
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

Review 5.  Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer.

Authors:  Himashinie V K Diyabalanage; Michael L Granda; Jacob M Hooker
Journal:  Cancer Lett       Date:  2012-09-29       Impact factor: 8.679

6.  NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging.

Authors:  M V P Nadella; W C Kisseberth; K S Nadella; N K Thudi; D H Thamm; E A McNiel; A Yilmaz; K Boris-Lawrie; T J Rosol
Journal:  Vet Comp Oncol       Date:  2008-03       Impact factor: 2.613

7.  Role for histone deacetylase 1 in human tumor cell proliferation.

Authors:  Silvia Senese; Katrin Zaragoza; Simone Minardi; Ivan Muradore; Simona Ronzoni; Alfonso Passafaro; Loris Bernard; Giulio F Draetta; Myriam Alcalay; Christian Seiser; Susanna Chiocca
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

8.  Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.

Authors:  L Marquard; L M Gjerdrum; Ib J Christensen; P B Jensen; M Sehested; E Ralfkiaer
Journal:  Histopathology       Date:  2008-09       Impact factor: 5.087

9.  A unified 35-gene signature for both subtype classification and survival prediction in diffuse large B-cell lymphomas.

Authors:  Yu-Dong Cai; Tao Huang; Kai-Yan Feng; Lele Hu; Lu Xie
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

10.  Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

Authors:  Chia Huey Ooi; Tatiana Ivanova; Jeanie Wu; Minghui Lee; Iain Beehuat Tan; Jiong Tao; Lindsay Ward; Jun Hao Koo; Veena Gopalakrishnan; Yansong Zhu; Lai Ling Cheng; Julian Lee; Sun Young Rha; Hyun Cheol Chung; Kumaresan Ganesan; Jimmy So; Khee Chee Soo; Dennis Lim; Weng Hoong Chan; Wai Keong Wong; David Bowtell; Khay Guan Yeoh; Heike Grabsch; Alex Boussioutas; Patrick Tan
Journal:  PLoS Genet       Date:  2009-10-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.